ArticleAmerican journal of clinical and experimental immunology2025

IGLL5 has potential to be a prognostic biomarker and its correlation with immune infiltrates in breast cancer.

Junchao Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.